To evaluate the timing and methods of symmetrization in therapeutic mammoplasty and its impact on patient quality of life, emphasizing the critical role of symmetry in post-operative satisfaction.
Key Findings:
72-100% of women notice asymmetry post-surgery, with 28-32% dissatisfied with outcomes, highlighting the need for effective symmetrization.
Immediate symmetrization has not shown increased complications or delays in adjuvant therapy, supporting its safety.
A dual-consultant approach for immediate symmetrization has demonstrated significant cost savings, making it a viable option.
Interpretation:
Immediate symmetrization is favored for its safety, cost-effectiveness, and positive impact on patient quality of life, while delayed symmetrization poses challenges that can affect patient satisfaction.
Limitations:
Lack of comprehensive data comparing outcomes of immediate versus delayed symmetrization, particularly in diverse patient populations.
Need for more prospective studies on patient-reported outcomes and cost-effectiveness to guide clinical practice.
Conclusion:
Immediate symmetrization should be prioritized to enhance patient satisfaction and reduce costs, with further research needed to optimize practices and validate findings.
